Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $287.25 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $113.75 | 4 | $0 (2021) |
| Alcon Vision LLC | $62.59 | 1 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $58.70 | 2 | $0 (2019) |
| Oyster Point Pharma, Inc. | $26.43 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $15.39 | 1 | $0 (2022) |
| Shire North American Group Inc | $10.39 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $26.43 | 1 | Oyster Point Pharma, Inc. ($26.43) |
| 2022 | $15.39 | 1 | Novartis Pharmaceuticals Corporation ($15.39) |
| 2021 | $14.11 | 1 | Allergan, Inc. ($14.11) |
| 2020 | $45.25 | 2 | Allergan, Inc. ($45.25) |
| 2019 | $87.59 | 2 | Alcon Vision LLC ($62.59) |
| 2018 | $88.09 | 2 | Allergan Inc. ($54.39) |
| 2017 | $10.39 | 1 | Shire North American Group Inc ($10.39) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: DRY EYE | ||||||
| 06/23/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/10/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: DRY EYE | ||||||
| 11/20/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: DRY EYE | ||||||
| 09/25/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/27/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | ULTRA (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2019 | Alcon Vision LLC | DAILIES (Device) | Food and Beverage | In-kind items and services | $62.59 | General |
| Category: Ophthalmology | ||||||
| 11/30/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BIOTRUE (Device), ULTRA, BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/04/2018 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $54.39 | General |
| Category: DRY EYE | ||||||
| 02/17/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: OPTHALMICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 633 | 728 | $104,550 | $32,829 |
| 2022 | 6 | 712 | 820 | $109,885 | $38,889 |
| 2021 | 7 | 868 | 1,026 | $124,990 | $50,537 |
| 2020 | 6 | 826 | 909 | $109,860 | $49,196 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 284 | 339 | $61,020 | $22,311 | 36.6% |
| 92250 | Photography of the retina | Office | 2023 | 180 | 193 | $19,300 | $3,941 | 20.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 77 | 88 | $11,440 | $2,870 | 25.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 35 | 46 | $6,900 | $2,525 | 36.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 43 | 46 | $4,370 | $820.87 | 18.8% |
| 92134 | Imaging of retina | Office | 2023 | 14 | 16 | $1,520 | $361.13 | 23.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 302 | 370 | $62,340 | $25,949 | 41.6% |
| 92250 | Photography of the retina | Office | 2022 | 186 | 189 | $18,900 | $4,045 | 21.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 89 | 108 | $12,420 | $3,784 | 30.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 47 | 60 | $8,320 | $3,167 | 38.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 61 | 64 | $5,440 | $1,237 | 22.7% |
| 92134 | Imaging of retina | Office | 2022 | 27 | 29 | $2,465 | $706.99 | 28.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 358 | 466 | $68,330 | $33,585 | 49.2% |
| 92250 | Photography of the retina | Office | 2021 | 226 | 232 | $23,200 | $5,397 | 23.3% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 106 | 135 | $15,525 | $5,204 | 33.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 60 | 69 | $7,980 | $3,801 | 47.6% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 81 | 86 | $7,310 | $1,898 | 26.0% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 24 | 25 | $2,125 | $544.56 | 25.6% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2021 | 13 | 13 | $520.00 | $107.25 | 20.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 376 | 434 | $61,200 | $32,678 | 53.4% |
| 92250 | Photography of the retina | Office | 2020 | 200 | 200 | $20,000 | $5,505 | 27.5% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 97 | 107 | $12,305 | $4,511 | 36.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 70 | 83 | $9,130 | $4,449 | 48.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 65 | 67 | $5,695 | $1,588 | 27.9% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 18 | 18 | $1,530 | $463.40 | 30.3% |
About Dr. Paul Cote, O.D
Dr. Paul Cote, O.D is a Optometrist healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144225475.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Cote, O.D has received a total of $287.25 in payments from pharmaceutical and medical device companies, with $26.43 received in 2023. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($287.25).
As a Medicare-enrolled provider, Cote has provided services to 3,039 Medicare beneficiaries, totaling 3,483 services with total Medicare billing of $171,450. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Lewiston, ME
- Active Since 06/14/2005
- Last Updated 09/19/2011
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1144225475
Products in Payments
- RESTASIS (Drug) $79.59
- DAILIES (Device) $62.59
- BIOTRUE (Device) $33.70
- TYRVAYA (Drug) $26.43
- XIIDRA (Drug) $25.78
- ULTRA (Device) $25.00
- LUMIGAN (Drug) $20.05
- RESTASIS MULTIDOSE (Drug) $14.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Lewiston
Dr. Daniel Evans, O.d, O.D
Optometrist — Payments: $3,923
Hannah Medwin, Od, OD
Optometrist — Payments: $2,764
Dr. Kevin Komm, O.d, O.D
Optometrist — Payments: $2,692
Dr. Douglas Henry, O.d, O.D
Optometrist — Payments: $1,581
Mr. Troy Avery, O.d, O.D
Optometrist — Payments: $1,137
Sheridon Gove, O.d, O.D
Optometrist — Payments: $665.91